Security...

Nothing To Fear...

Pilates...

Temporary...

CornerStone...

Peace with Russia is the corner-stone for stability of the world particularly Europe and the Middle East. Just a thought.

Roach Motel...?

Spoof...*

Pervasive Telephone Scams.
The IRS has reported an increase in phone scams across the country, with callers pretending to be from the agents or other IRS representatives in hopes of stealing money or identities from victims. There are a number of variations on a theme ranging from instances from where callers say the victims owe money or are entitled to a huge refund to calls which threaten arrest.  The IRS has noted a few patterns in these calls such as:

• Scammers use fake names and IRS badge numbers. They generally use common names and surnames to identify themselves.
• Scammers may be able to recite the last four digits of a victim’s Social Security Number.
• Scammers “spoof” or imitate the IRS toll-free number on caller ID.
• Scammers sometimes send bogus IRS emails to some victims to support their bogus calls.
• Victims hear background noise of other calls being conducted to mimic a call site.
• After threatening victims with jail time or a driver’s license revocation, scammers hang up and others soon call back pretending to be from the local police or DMV, and the caller ID supports their claim 

Back Then...?

Unused...

The study, published in BMJ (formerly the British Medical Journal), details how drugmakers, hospitals and cancer doctors make money on unused cancer medicine. It focuses on the top 20 drugs for multiple cancer types packaged in single-dose vials and for which the dose depends on the patient's weight, finding that 1% to 33% of those 20 cancer drugs, on average, remains in vials after each dose is administered.

Insurers and cancer patients will pay at least another $1 billion on unused medicine in 2016, based on the markups hospitals and doctors charge over a vial's price every time they infuse patients with those cancer drugs, the researchers concluded.

"Some of these drugs are selling for ... 1,000 times the price of gold," said Bach, director of Memorial Sloan Kettering's Center for Health Policy and Outcomes. He said their prices are "breaking the stratosphere," with many costing $15,000 per month or more.

The researchers said Merck's hot new melanoma drug Keytruda initially was sold in the U.S. in 50-milligram vials, but the company switched to just 100-milligram vials in the U.S. in February 2015.   boosting Merck's revenue from leftover Keytruda from $500 to $3,000 per patient dose.

In Europe and other places where regulators have more control over drug prices and dose sizes, more vial sizes typically are available, limiting waste. 

Frightened...